All Regenerative Medicine articles – Page 3

  • Adaptive-Bio---Sharon-Benzeno
    Article

    Neoantigen-directed cancer treatment

    2023-06-09T14:00:01Z

    This exclusive interview with Dr Sharon Benzeno, Chief Commercial Officer, Immune Medicine at Adaptive Biotechnologies, explores research on T-cell therapy for cancer, which has seen the first TCR-based therapeutic candidate progress to clinical development, offering promising advancements in innovative cancer treatments.